31

Dr. Sunita Tandulwadkar, an Infertility Specialist and Gynecology Endoscopist from Pune, is currently conducting groundbreaking research in reproductive medicine. BE’s Saptarshi Deb interviewed her about her work.

Q. What is the essence of “Autologous Stem Cells and IVF,” and how does it impact fertility treatments?

A. The essence of “Autologous Stem Cells and IVF” lies in its innovative approach to enhancing fertility treatments by integrating autologous cell fractions. These cells, derived from the patient’s own body, are used to improve ovarian function and increase both the quality and quantity of eggs produced. This method addresses infertility challenges that traditional IVF may not fully overcome, particularly in women with diminished ovarian reserve. By rejuvenating the ovarian environment, IVF with autologous cell fractions enhances pregnancy success rates, offering new hope to couples struggling with infertility, especially those who have experienced multiple failed IVF attempts. This represents a significant advancement in personalized reproductive medicine.

Q. How does Embryo Transfer IVF technology revolutionize reproductive medicine, emphasizing quality over quantity in achieving successful pregnancies?

A. Embryo Transfer IVF technology revolutionizes repro-ductive medicine by focusing on the quality of embryos rather than the quantity. This approach involves cultivating embryos to the blastocyst stage, which ensures higher viability and better implantation potential. By selecting the best-quality blastocyst for transfer, the chances of successful pregnancies are significantly increased while minimizing the risks of multiple pregnancies. This method prioritizes the health and well-being of both the mother and the baby, aiming for healthier, full-term pregnancies with fewer complications.

Q. How does Solo Cell Regenerative Treatment differ from other IVF treatments?

A. Solo Cell Regenerative Treatment distinguishes itself from conventional IVF by incorporating autologous cell fractions to enhance reproductive health. Unlike traditional IVF, which relies primarily on hormonal stimulation to produce eggs, Solo Cell Therapy focuses on rejuvenating the ovarian environment to improve egg quality and ovarian response. This method addresses underlying issues such as ovarian aging and poor egg quality, which are common challenges in fertility treatments. By using the patient’s own cells, Solo Cell Therapy reduces the risk of immune reactions and offers a more natural enhancement of fertility, providing a tailored solution for specific reproductive issues.

Q. What are the trends and changes in the demand for IVF and cell fraction therapy in India over the past few years? Also, how true is the perception that IVF leads to twin babies?

A. In recent years, there has been a significant increase in the demand for IVF and cell fraction therapies in India, particularly for fertility treatments. These therapies have gained popularity due to their promising results in improving reproductive health and supporting successful pregnancies. The belief that IVF inevitably leads to twin babies is a misconception from the early days of IVF when multiple embryos were often transferred to improve success rates. With advancements in embryo selection and transfer techniques, the likelihood of multiple pregnancies has been greatly reduced. The current focus is on single, high-quality embryo transfers to achieve healthy, singleton pregnancies.

Q. Can women over 40 give birth to healthy babies, and how has Solo Cell Therapy contributed to successful pregnancies in this age group?

A. Yes, women over 40 can indeed give birth to healthy babies using their own eggs, and Solo Cell Therapy has been instrumental in achieving successful pregnancies for this age group. As women age, the quality and quantity of their eggs typically decline, making conception more challenging. Solo Cell Therapy helps by rejuvenating the ovarian environment, potentially improving egg quality, quantity, and overall ovarian function. This treatment has shown promising results in enhancing fertility outcomes for older women, thereby increasing their chances of having healthy pregnancies and babies. Its personalized approach makes it a viable option for those facing age-related fertility challenges.